Fri, 04th Jul 2014 08:59
LONDON (Alliance News) - e-Therapeutics PLC Friday said Finance Director Steve Medlicott bought 100,000 shares at a price of 29 pence per share Thursday. The shares represent his only holding in the company.
Shares in the research and development company were down 5.3% at 27.00p Friday.
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2014 Alliance News Limited. All Rights Reserved.
(Sharecast News) - RNAi medicines data and development specialist e-Therapeutics proposed a fundraise and its delisting from AIM on Wednesday.
(Alliance News) - e-Therapeutics PLC on Wednesday announced its intention to cancel its admission to AIM and instead explore the option of listing on ...
e-Therapeutics PLC - Oxford, England-based computer-based drug discovery company - Says 2023 was
e-Therapeutics PLC - Oxford, England-based computer-based drug discovery company - Says that its shares will cease to trade on the OTCQX Best Market i...
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...